The companies said they plan to explore a range of questions including the clinical implementation of the Alzheimer's disease biomarker phosphorylated tau 217.
Last week, readers were most interested in Labcorp's acquisition of assets from MAWD, a CE mark for Roche's mass spec system, and features on Volition and Siemens Healthineers.
Consolidation within the industry also remained brisk as cost and reimbursement concerns provided acquisition opportunities for large national outfits.
The company consolidated its instrument lineup with its newer Atellica instruments and is phasing out support for Advia and Dimension branded analyzers through 2030.
Under the agreement, Labcorp will manage Graves Gilbert's main full-service laboratory in Bowling Green, Kentucky and its facility in Glasgow, Kentucky.
The deal for shares and cash is expected to close in the first half of 2025, and Sonic expects that it will be immediately accretive to earnings per share.
The US Centers for Disease Control and Prevention will support proof-of-concept development of primers and probes by Hologic for a laboratory-developed test.